AltPep
Nancy has a track record of building and growing innovation-driven life science companies. With extensive experience in biopharmaceutical, medical device and diagnostics companies and strengths in product development, commercialization and operations, she has built global businesses leading to multiple successful exits. Most recently, Nancy was Executive Vice President of Operations and Program Management at Adaptive Biotechnologies and a member of the core executive team that grew the company from early start-up through IPO to a multi-billion dollar peak market cap. Nancy is also President of the Seattle Chapter of the Healthcare Businesswomen’s Association.
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).